| Issue |
Section |
Title |
File |
| Vol 19, No 4 (2022) |
Original studies |
Efficacy and predictors of rapid response to omalizumab therapy in patients with seasonal allergic rhinitis: a cohort study |
(Rus)
|
| Vol 19, No 3 (2022) |
Original studies |
Epidemiology of chronic inducible urticaria in Moscow |
(Rus)
(Eng)
|
| Vol 20, No 1 (2023) |
Reviews |
Chronic-induced urticaria; classification, actual aspects of diagnosis and therapy |
(Rus)
(Eng)
|
| Vol 20, No 1 (2023) |
Original studies |
Cholinergic urticaria: search for predictors of course severity and response to therapy |
(Rus)
|
| Vol 21, No 1 (2024) |
Original studies |
Analysis of the sensitization spectrum in patients with severe allergic diseases using the ImmunoCAP ISAC method |
(Rus)
|
| Vol 21, No 2 (2024) |
Original studies |
New coronavirus infection SARS-CoV-2 in adult patients with inborn errors of immunity |
(Rus)
|
| Vol 21, No 1 (2024) |
Original studies |
Clinical-anamnestic analysis of patients diagnosed as "Anaphylaxis" hospitalized in Moscow medical hospitals |
|
| Vol 21, No 1 (2024) |
Original studies |
Analysis of patients with cold urticaria in the context of typical and atypical forms |
(Rus)
|
| Vol 22, No 1 (2025) |
Original studies |
Artificial intelligence tools for phenotyping patients with anaphylaxis |
|
| Vol 22, No 1 (2025) |
Case reports |
Recurrent angioedema with normal C1-inhibitor: genetics determine the endotype |
|
| Vol 22, No 3 (2025) |
Original studies |
Clinical and anamnestic analysis of patients with Stevens–Johnson syndrome/toxic epidermal necrolysis hospitalised in Moscow. Development of a prognostic model of unfavourable outcomes |
|
| Vol 22, No 2 (2025) |
Original studies |
ASIA syndrome masked as recurrent angioedema: сan development be predicted by genetic screening (pilot study) |
(Rus)
|
| Vol 22, No 3 (2025) |
Case reports |
Andogsky syndrome: experience with anti-IL-4, 13 therapy |
|
